BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Zhou G, Zhou W, Wang X, Wang X, Miao C. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease. Pharmaceutics 2021;13:1644. [PMID: 34683937 DOI: 10.3390/pharmaceutics13101644] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sanz-Ros J, Mas-Bargues C, Romero-García N, Huete-Acevedo J, Dromant M, Borrás C. Extracellular Vesicles as Therapeutic Resources in the Clinical Environment. Int J Mol Sci 2023;24. [PMID: 36768664 DOI: 10.3390/ijms24032344] [Reference Citation Analysis]
2 Shan L, Zhan F, Lin D, Feng F, Chen X, Li X, Yang D. SIRT1-Enriched Exosomes Derived from Bone Marrow Mesenchymal Stromal Cells Alleviate Peripheral Neuropathy via Conserving Mitochondrial Function. J Mol Neurosci 2022;72:2507-16. [PMID: 36534294 DOI: 10.1007/s12031-022-02091-x] [Reference Citation Analysis]
3 Xu L, Zhu Y, Li C, Wang Q, Ma L, Wang J, Zhang S. Small extracellular vesicles derived from Nrf2-overexpressing human amniotic mesenchymal stem cells protect against lipopolysaccharide-induced acute lung injury by inhibiting NLRP3. Biol Direct 2022;17:35. [PMID: 36447296 DOI: 10.1186/s13062-022-00351-9] [Reference Citation Analysis]
4 Hu X, Zhang R, Liang H, An J, Yang Y, Huo J, Chen Z, Quan W, Jiang L, Li C, Li J, Li F, Xu Y, Zhu X. Comparison and Investigation of Exosomes from Human Amniotic Fluid Stem Cells and Human Breast Milk in Alleviating Neonatal Necrotizing Enterocolitis. Stem Cell Rev and Rep 2022. [DOI: 10.1007/s12015-022-10470-5] [Reference Citation Analysis]
5 Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, Zhang Y, Tian CM, Nie YQ, Shi RY, Wang LS, Yao J. Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease. Int J Nanomedicine 2022;17:3893-911. [PMID: 36092245 DOI: 10.2147/IJN.S370784] [Reference Citation Analysis]
6 Li DF, Yang MF, Xu HM, Zhu MZ, Zhang Y, Tian CM, Nie YQ, Wang JY, Liang YJ, Yao J, Wang LS. Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease. J Mater Chem B 2022. [PMID: 35876136 DOI: 10.1039/d2tb01190e] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ocansey DKW, Zhang Z, Xu X, Liu L, Amoah S, Chen X, Wang B, Zhang X, Mao F. Mesenchymal stem cell-derived exosome mitigates colitis via the modulation of the gut metagenomics-metabolomics-farnesoid X receptor axis. Biomater Sci 2022. [PMID: 35858469 DOI: 10.1039/d2bm00559j] [Reference Citation Analysis]
8 Wang Y, Huang B, Jin T, Ocansey DKW, Jiang J, Mao F. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Front Immunol 2022;13:835005. [DOI: 10.3389/fimmu.2022.835005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tie S, Tan M. Current Advances in Multifunctional Nanocarriers Based on Marine Polysaccharides for Colon Delivery of Food Polyphenols. J Agric Food Chem . [DOI: 10.1021/acs.jafc.1c05012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]